Race and Sex Differences in Silent Myocardial Infarction Incidence and Prognosis: ARIC Study

This ARIC (Atherosclerosis Risk in Communities) prospective cohort study followed 9,498 biracial (Black and White) participants over a median 8.9 years, identifying silent myocardial infarctions (SMIs) — detected by ECG changes without recognized clinical presentation — and comparing their incidence and prognosis with clinically manifest MI.

Silent MI accounted for 45% of all incident MIs. Annual incidence rates were 5.08 per 1,000 person-years for SMI in men versus 2.93 in women; Black participants had a nonsignificantly higher SMI rate than White participants but lower clinically manifest MI rates. Both SMI and CMI substantially increased CHD death risk: SMI HR 3.06 and CMI HR 4.74, compared with no MI. All-cause mortality: SMI HR 1.34 and CMI HR 1.55. Women showed potentially greater mortality impact from SMI despite lower incidence.

The finding that 45% of all MIs are silent — unrecognized at the time of occurrence and detected only by later ECG changes — is a fundamental challenge to clinical prevention strategies. Standard symptom-based prevention relies on the assumption that cardiovascular events announce themselves through recognizable chest pain, allowing treatment escalation. Nearly half of all MIs bypass this signal entirely.

For subclinical CAD detection, this data is directly motivating: if half of all MIs are silent, the downstream event cannot be relied upon to trigger prevention. Identifying subclinical coronary atherosclerosis — through CAC scoring, CCTA, or biomarker profiling — before the silent MI occurs is the only strategy that addresses this population.

We rate the evidence strong. A large prospective ARIC cohort study demonstrating that silent MI accounts for 45% of all incident MIs and carries comparable mortality risk to clinically recognized MI — foundational evidence for the importance of subclinical disease detection rather than waiting for clinical events.